Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-043511
Filing Date
2025-05-01
Accepted
2025-05-01 16:02:16
Documents
1
Period of Report
2025-04-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2513725-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2513725-4_4seq1.xml 4 3975
  Complete submission text file 0001104659-25-043511.txt   5790
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Issuer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SCORPIUS HOLDINGS, INC. 627 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560
Business Address
Wolf Jeffrey Alan (Reporting) CIK: 0001381450 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12584 | Film No.: 25902875